1. Xue Yimeng#, Zeng Chaofan#, Ge Peicong, Liu Chenglong, Li Junsheng, Zhang Yan, Zhang Dong, Zhang Qian*, Zhao Jizong*.Association of RNF213 Variants With Periventricular Anastomosis in Moyamoya Disease.Stroke.2022.53(9).2906-2916.SCI |
2. Ge Peicong, Zhang Qian*, Ye Xun, Liu Xingju, Deng Xiaofeng, Wang Jia, Wang Rong, Zhang Yan, Zhang Dong, Zhao Jizong*.Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study.Stroke.2020.51.2472-2479.SCI |
3. Ma Yonggang, Zhao Meng, Deng Xiaofeng, Zhang Dong, Wang Shuo, Zeng Zheng, Zhang Qian*, Zhao Jizong*.Comparison of clinical outcomes and characteristics between patients with and without hypertension in moyamoya disease.Journal of Clinical Neuroscience.2020.75.163-167.SCI |
4. Zhang Qian, Zhao Meng, Ge Peicong, Liu Xingju, Wang Rong, Zhang Yan, Zhang Dong, * Zhao Jizong*.Hemorrhagic patterns and their risk factors in patients with moyamoya disease.European Journal of Neurology.2020.27(12).2499-2507.SCI |
5. Zhang Qian, Ge Peicong, Ma Yonggang, Zhang Dong, Wang Rong, Zhang Yan, Wang Shuo, Cao Yong, Zhao Meng, Zhao Jizong*.Clinical Features and Surgical Outcomes of Patients With Moyamoya Disease and the Homozygous RNF213 p.R4810K Variant.Journal of Child Neurology.2019.34(13).793-800.SCI |
6. Ge Peicong,Ye Xun, Liu Xingju,Deng Xiaofeng,Wang Rong,Zhang Yan,Zhang Dong,Zhang Qian*; Zhao Jizong*.Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease.Frontiers in Neurology.2019.10.662.SCI |
7. Ge Peicong#, Zhang Qian#, Ye Xun, Wang Shuo, Zhang Dong, Zhao Jizong*.Clinical Features, Surgical Treatment, and Long-Term Outcome in Children with Hemorrhagic Moyamoya Disease.Journal of Stroke & Cerebrovascular Diseases.2018.27(6).1517-1523.SCI |
8. Zhang Qian#, Yu Lebao#, Ge Peicong, Ma Yonggang, Zhang Dong, Zhang Yan, Wang Rong, Wang Shuo, Zhao Yuanli, Cao Yong, Liu Xingju, Deng Xiaofeng, Zhao Jizong*.Association of Ring Finger Protein 213 Gene P.R4810k Polymorphism with Intracranial Major Artery Stenosis/Occlusion.Journal of Stroke & Cerebrovascular Diseases.2018.27(6).1556-1564.SCI |
9. Zhang Qian#, Liu Yaping#, Yu Lebao, Duan Ran, Ma Yonggang, Ge Peicong, Zhang Dong, Zhang Yan, Wang Rong, Wang Shuo, Zhao Yuanli, Cao Yong, Liu Xingju, Deng Xiaofeng, Zhao Jizong*, Zhang Xue*.The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.World Neurosurg.2017.99.701-708.e1.SCI |
10. Zhang Qian#, Si Nuo#, Liu Yaping, Zhang Dong, Wang Rong, Zhang Yan, Wang Shuo, Liu Xingju, Deng Xiaofeng, Ma Yonggang, Ge Peicong, Zhao Jizong*, Zhang Xue*.Steroid sulfatase and filaggrin mutations in a boy with severe ichthyosis, elevated serum IgE level and moyamoya syndrome.Gene.2017.628.103-108.SCI |
11. Zhang Qian#, Liu Yaping#, Zhang Dong, Wang Rong, Zhang Yan, Wang Shuo, Yu Lanbing, Lu Chaoxia, Liu Fang, Zhou Jian, Zhang Xue, Zhao Jizong*.RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.JOURNAL OF NEUROSURGERY.2017.126(4).1106-1113.SCI |
12. Zhang Qian#, Wang Rong#, Liu Yaping, Zhang Yan, Wang Shuo, Cao Yong, Zhao Yuanli, Liu Xingju, Wang Jia, Deng Xiaofeng, Gao Faliang, Yang Ziwen, Zhao Meng, Ge Peicong, Ma Yonggang, Zhao Jizong*, Zhang Dong*.Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.World Neurosurg.2016.96.474-482.SCI |
13. Zhang Qian#, Zhang Dong#, Wang Rong, Liu Yaping, Zhang Yan, Wang Shuo, Zhao Jizong*.Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.World Neurosurg.2016.90.530-538.e3.SCI |